Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaBAM is a Swiss-based specialty pharmaceutical company that focuses on the development, registration, and licensing of Value Added Medicines (VAMs) and niche generic products. By leveraging innovative formulation technologies, the company enhances the therapeutic profile of established off-patent molecules to address specific clinical needs and improve patient adherence. PharmaBAM operates a business-to-business model, providing high-quality product dossiers and intellectual property to global partners for commercialization. Their expertise spans several therapeutic areas, with a particular emphasis on pain management, central nervous system disorders, and respiratory health. The company is headquartered in Lugano and maintains a lean, expert-driven organizational structure. PharmaBAM's portfolio includes injectable formulations of common analgesics and specialized oral delivery systems for CNS medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaBAM.